A rapid, accurate and sensitive liquid chromatography -tandem mass spectrometry method has been developed for the determination of a quaternary nitrogen muscle relaxant, rocuronium, in human blood. The procedure involves protein precipitation with chloroform and trichloroacetic acid, and purification using methanol. The chromatography was performed using a phenyl-hexyl column (150 3 2.0 mm i.d., 3 mm; Phenomenex) with a mobile phase consisting of 5 mM ammonium formate ( pH 3.0) and acetonitrile. Multiple reaction monitoring was used for quantification. The assay was linear over a concentration range of 4-500 ng/mL for rocuronium with R 2 ! 0.998. The recoveries for this compound ranged from 96.0 to 109.1%. The intra-day and inter-day precision was less than 10.5% and the accuracy ranged from 106.6 to 114.9%. The validated method was applied to quantify the content of rocuronium in blood and a variety of tissues of a victim suspected of overdose. In conclusion, the method was successfully applied for the analysis of rocuronium in biological samples for forensic toxicology.
Introduction
Rocuronium is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant that is widely used in modern anaesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It competes with acetylcholine (Ach) molecules and binds to muscarinic acetylcholine receptors on the postsynaptic membrane of the motor endplate. Rocuronium has rapid onset and intermediate duration of action (1, 2) .
Rocuronium has sometimes been involved in forensic toxicology in cases of suicide, homicide or malpractice. Therefore, it was necessary to develop a convenient analytical method for rocuronium in biological samples because it is difficult to extract and to analyze rocuronium because of the lack of thermal stability and a chromophore, and the presence of a permanent positive charge.
The determination of rocuronium in biological specimens has been reported using high-performance liquid chromatography (HPLC) (3 -8) or gas chromatography (GC) with nitrogensensitive detection (9, 10) , GC-mass spectrometry (MS) (11) , LC-electrospray ionization (ESI)-MS (12 -15) or LC-tandem mass spectrometry (MS-MS) (16, 17) . The HPLC method requires post-column ion pair extraction with a second pump device (4) . With GC analysis coupled to a nitrogen detector, the derivatization of rocuronium was accomplished with N-methyl-N-(tert-butyldimethylsilyl)-trifluoroacetamide (9, 10).
Some reported LC-ESI-MS and GC-MS methods require iodide ion pair formation due to the positive charge of rocuronium (9, 12) . Thus, the previously reported sample preparation methods, especially the ion pairing reaction and derivatization procedure, are time-consuming and work-intensive. An ionpairing LC method has been described, but it may be harmful in the column and ion source. Furthermore, there are no reports of the determination of rocuronium without ion pairing formation or derivatization. This study utilized a relatively simple preparation of blood samples, and the proposed method also offers increased recovery when compared to previous methods. Therefore, a simple and sensitive determination method has been developed and validated for rocuronium in human whole blood using LC-MS-MS; this method was successfully applied to quantify the content of rocuronium in the blood and a variety of tissues (bile, urine, brain and liver) of a victim of suspected overdose.
Experimental
Reagents and chemical Rocuronium (!98% purity) and vecuronium (!97% purity) were purchased from Sigma (St. Louis, MO). Acetonitrile, chloroform, ammonium formate and methanol were HPLC-grade solvents purchased from Fischer Scientific Co. (Fair Lawn, NJ), and trichloroacetic acid (TCA) was from Merck Company (Darmstadt, Germany). Water was prepared using the Milli-Q water purification system (Millipore, Bedford, MA). All other reagents were of analytical grade. Drug-free human blood was supplied by the National Forensic Service (NFS, Korea).
Instruments
HPLC was performed using an Agilent 1100 series HPLC system with a degasser, a binary pump, a thermostated autosampler, a column oven controller and a switching valve system (Agilent Technologies, Palo Alto, CA). Mass spectrometric detection was conducted on an API 3000 triple quadrupole mass spectrometer (Applied Biosystems, MDS Sciex, Concord, Canada). Instrument settings, data acquisition and processing were controlled by the software package Analyst (Version 1.5.1, Applied Biosystems). Phenomenex). The mobile phases consisted of 5mM ammonium formate in water ( pH 3.0) (A) and acetonitrile (B). The gradient elution was conducted at the following flow rates: 0.2 mL/min for 0 -2 min with 90% B; 2 -8 min with 90 -10% B; 8 -13 min with 10% B; 13-15 min with 10 -90% B; 15 -20 min with 90% B. The column temperature and autosampler were maintained at 30 and 108C, respectively.
Mass spectrometric conditions
The mass spectrometer was operated in the positive ion mode using an ESI source. The MS operating condition was optimized for rocuronium and vecuronium [internal standard (IS)] by directly infusing analytes using a syringe pump (Holliston, Harvard, MA). The mass spectrometer settings were optimized as follows: ion spray voltage, 5.5 kV; turbo ion source temperature, 3208C; declustering potential (DP), 70 V (rocuronium) and 25 V (vecuronium); collision energy (CE), 45 V (rocuronium) and 20 V (vecuronium); collision exit potential (CXP), 10 V; entrance potential (EP), 10 V; nebulizer gas flow, 5 L/ min; auxiliary gas flow, 7 L/min; curtain gas flow, 10 L/min; collision gas (nitrogen) pressure, 2.3 Â 10 25 Torr; dwell time, 200 ms. Quantification was performed in multiple reaction monitoring (MRM) mode. The selected transitions were m/z 529 ! 487 for rocuronium and m/z 279 ! 249 for vecuronium (IS). Unit mass resolution was used in Q1 and Q3.
Preparation of calibration standards and quality control samples Stock standard solutions of rocuronium and vecuronium (IS) were prepared separately by dissolving the dry chemical powder in methanol to achieve a concentration of 100 mg/mL. Working solutions were prepared through serial dilution of the stock standard solutions with methanol. Calibration standards of rocuronium at concentrations of 4, 20, 100, 200 and 500 ng/ mL were prepared by spiking appropriate amounts of the standard solutions in drug-free blank human blood. Quality control (QC) samples were prepared independently in blank human blood at concentrations of 10, 50 and 400 ng/mL (low, medium and high QC levels). All of the solutions were stored at -208C prior to analysis.
Sample preparation
To a 0.5 mL aliquot of a human whole blood sample in a 2.0 mL Eppendorf tube, 0.7 mL of chloroform, 0.1 mL of IS (5 mg/mL) and 0.5 mL of 10% TCA were added. The mixture was vortexmixed for 3 min and centrifuged at 10,000 g for 5 min. The supernatant was transferred and evaporated to dryness under nitrogen at 358C. The residue was dissolved in 0.25 mL of methanol. After vortexing (3 min) and centrifugation (5 min at 10,000 g), the supernatant was dissolved in 0.1 mL of methanol. A 10 mL aliquot was injected into the HPLC -MS-MS system.
Method validation
The interferences from endogenous compounds were investigated by the analysis of three different human blank blood samples. The peak areas needed to be less than 20% of the peak areas of the limit of quantitation (LOQ) for rocuronium and vecuronium (IS) in blood.
A calibration curve was constructed by plotting the peak area ratios ( y) of the analyte to the IS versus the concentrations of the analyte (x) in the spiked blood. The LOQ for the assay was defined as the lowest concentration that could be measured with the percent relative standard deviation (RSD) and percent relative error (RE) of , 20%, as determined from spiked blood samples. The limit of detection (LOD) was defined as the lowest concentration of rocuronium that produced a signal-to-noise ratio of 3.
The intra-day and inter-day assays were determined by analyzing QC samples at three levels three times on a day and three separate days. Precision was measured as the RSD for the experimentally determined concentrations, and accuracy was calculated as the percentage of deviation from the nominal concentration. The criteria for the acceptability of data included accuracy within +15% of deviation from the nominal values and a precision within +15% of RSD, except for the lowest LOQ, which was not to exceed 20% of RSD.
The extraction recoveries of analyte were determined at three concentration levels (10, 50 and 400 ng/mL) by comparing the ratios of the peak area of rocuronium to the peak areas of the IS. Samples that were spiked with the analyte prior to extraction were compared with the reference samples to which the analyte was added post-extraction.
Because the endogenous substances or co-eluting matrix components may have potential effects of ion suppression or enhancement on the analyte, the matrix effect (ME) was investigated. It was evaluated by comparing the peak ratios of the peak area of rocuronium to IS obtained from blood samples spiked after extraction with those from neat standards at the same concentrations. The blank blood samples used in this study were from three different batches of drug-free postmortem blood.
Results and Discussion
ESI-MS-MS spectra ESI operated in positive ion mode was used for the LC-MS-MS analysis. The mass spectra of rocuronium and vecuronium showed M þ molecular ions and [M þ H] 2þ monoprotonated ions (12, 13) . The mass spectrum for rocuronium revealed a base peak ion at m/z 529 by the existing quaternary ammonium salt and a weak peak ion at m/z 265 by the monoprotonated species. The base peak ion of vecuronium was at m/z 279, which means the doubly charged molecular ion [M þ H] 2þ . Singly charged molecules (M þ ) of vecuronium (m/z 557) were also found in the spectra. To improve the sensitivity, nonacidic eluents were studied to avoid protonation of the analytes, and thus, to detect only M þ , but using an acidic mobile phase provided good and sharp peak shapes. Vecuronium seems likely to more easily ionize by the protonation of basic sites than rocuronium with the use of an acidic mobile phase. The mobile phase was designed to improve the sensitivity of major ions and suppress the sensitivity of byproduct ions. The Q1 and Q3 mass spectra of rocuronium and vecuronium are shown in Figure 1 . The major product ion for rocuronium (the most abundant rocuronium product ion) was at m/z 487 by deacetylation (12) . The mass spectrum of rocuronium contained a peak at m/z 112, which suggests the fragmentation of allylpyrrolidine moieties m/z 413, 376 and 70. The major product ion for vecuronium was at m/z 249. The mass spectrum of vecuronium contained peaks at m/z 100, 149, 98 and 100, which indicates the fragmentation of methylpiperidine moieties (13) . The MRM transitions at m/z 529 ! 487 for rocuronium and m/z 279 ! 249 for IS were the most intense ones, and thus were used as the quantifiers. These fragment ions were assigned by their structures and are very useful for the identification of rocuronium and vecuronium muscle relaxants in a sample.
HPLC separation
Liquid-liquid extraction (LLE) was used for the sample preparation in this work. LLE can be helpful in producing a clean sample and avoiding the introduction of non-volatile materials onto the column and MS system. Clean samples are essential for minimizing ion suppression and ME in LC-MS-MS analyses. Four organic solvents, chloroform, dichloromethane, methanol and acetonitrile, were evaluated to determine the most efficient protein participation. Finally, chloroform was found to be optimal, which produced a clean chromatogram for a blank blood sample and yielded the highest recovery for the analyte from the spiked blood samples. Additionally, 10% TCA and methanol were used to clean up. Using these solutions provided the elimination of lipophilic substances and protein precipitation in biological samples. The previously reported sample ion pairing reaction and derivatization methods and the use of an ion exchange column consume time and labor, whereas the extraction procedure described here will make it possible to easily prepare samples and simply detect rocuronium in biological samples.
Vecuronium, structurally similar to rocuronium, was selected as an IS due to its similar retention times and chromatographic properties.
Various chromatographic conditions, especially the column and the composition of mobile phase, were investigated to optimize the sensitivity and peak shape and to provide a short run time. Finally, a mixture of acetonitrile and 10 mM ammonium formate on a Phenomenex phenyl-hexyl column was adopted for the detection of analytes. Figure 2 shows typical chromatograms of drug-free blood (2A); spiked blood at limit of quantitation at 4 ng/mL (2B); and blood from a victim (2C). Rocuronium and IS were not detected in the blank blood. These chromatograms revealed no interfering peak derived from the endogenous components at the elution times of rocuronium and the IS.
Linearity and LOQ
The calibration curve of rocuronium was linear over the concentration range of 4-500 ng/mL. The regression equation was y ¼ 0.1812x þ 2.1283 and the correlation coefficient (r 2 ) for calibration curves was greater than 0.998. Good linearity was obtained in this concentration range.
The LOD was 0.6 ng/mL, defined by the concentration of analytes producing a signal-to-noise (S/N) ratio of 3. The LOQ was 4 ng/mL, defined by the lowest concentration in the linear range that could be detected with a variation within 11.9%. 
Precision and accuracy
The results of the precision and accuracy are presented in Table I . The intra-day accuracy was from 106.6 to 112.3% and the precision was from 7.5 to 10.5%. The inter-day accuracy was from 109.6 to 114.9% and the precision ranged from 1.4 to 6.9%. These values were within the acceptable ranges; this method is considered to be accurate, precise and reproducible for detecting rocuronium in human blood.
The carryover effect was investigated by injection of a methanol blank following the highest extracted calibrator. No carryover effect was found. This was the reason that the peak area in the methanol blank was less than 20% of the determined LOQ.
Recovery and matrix effect
The recovery and ME of rocuronium in blood samples are listed in Table II . Recoveries were estimated from mean values of five replicates at low, medium and high QC levels. The results of the recovery ranged from 96.0 to 109.1%.
The ME was essentially considered with the previously described simple and fast pretreatment method of biological samples. It was investigated to validate this sample pretreatment method because in general, MEs are directly related to an insufficient cleanup of the biological sample under investigation. No ME or interferences from endogenous compounds were detected for the three different sources of human blood. If the peak area ratio is less than 85% or more than 115%, an endogenous ME is implied. In the present study, the MEs at concentrations of 10, 50 and 400 ng/mL were 85.3 + 7.1, 87.6 + 4.1 and 91.2 + 5.3%, respectively. The results were well within the acceptable limit.
Application
A 41-year-old female fell down and hurt the forth finger of her right hand and wrist. She went to the hospital and she was given anesthetics and muscle relaxant in surgery. Doctors tried to tracheally intubate her to allow her to breathe, but failed. Therefore, she died before the surgery ever happened. The authors first questioned whether the overdose of muscle relaxant may have induced asphyxia following respiratory muscle paralysis. An autopsy was performed and the following samples were taken for toxicological analyses: heart blood, peripheral blood, stomach contents, bile, urine, liver and brain.
The validated method was then applied to a sample analysis for the victim. A chromatogram of the victim's blood sample is presented in Figure 2 , and the calculated concentrations of rocuronium were 64.2, 146.3, 728.7, 20.2 and 165.8 ng/mL, for heart blood, peripheral blood, bile, liver and brain, respectively. Rocuronium undergoes metabolism and the metabolite 17-desacetylrocuronium has weak neuromuscular blocking activity. Up to 30% of the dose is excreted in urine, with the majority excreted in bile. The blood concentration of the victim was within the clinical relaxation concentration range (2).
Conclusion
An HPLC -MS-MS method was developed for the determination of rocuronium in human blood. This method is simple, specific, accurate and precise, and can easily be implemented into routine practice. Compared to the previously published papers, this method greatly reduces the time and work in sample preparation. The present method utilized a simpler and more reproducible extraction method of rocuronium without adding ion pairing reagents or going through a derivatization procedure. This method has been validated and successfully applied to a forensic case, and it can be useful to forensic and clinical studies. 
